Plain-English translation of NCT06589765 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Type 2 Diabetes research guide →Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing a new medication called HRS-7535 to see how well it helps control blood sugar in people with type 2 diabetes. You would be taking this medication alongside your current metformin treatment. The study will compare this new treatment to dapagliflozin, another diabetes medication, to find out which works better and is safer.
Even with metformin treatment, many people with type 2 diabetes still struggle to keep their blood sugar at healthy levels. This trial exists to see whether this medication could be a better option to help more people achieve good blood sugar control.
You likely qualify if…
You likely don't qualify if…
You would take a tablet of the new medication by mouth at one of three different doses, or you would take dapagliflozin—the exact group would be chosen randomly. You will continue taking your metformin as usual. Throughout the trial, you will visit the clinic for check-ups and blood tests to see how well the medication is working and to make sure it is safe. The study will enroll about 800 people total.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
China